Cas No.: | 1109276-89-2 |
Chemical Name: | PF-04620110 |
Synonyms: | 2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid;2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f]-[1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid;{trans-4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl}acetic acid;AK120439;CHEMBL1835919;CS-0370;SureCN1424359;SureCN1424362;SureCN1425038;trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-cyclohexaneacetic acid;trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid;PF-04620110 |
SMILES: | O=C(C[C@@H]1CC[C@H](CC1)C2=CC=C(C=C2)N3CCOC4=NC=NC(N)=C4C3=O)O |
Formula: | C21H24N4O4 |
M.Wt: | 396.43966 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | PF-04620110 is an orally active, selective and potent diglyceride acyltransferase-1 (DGAT1) inhibitor with IC50 of 19 nM.For the detailed information of PF-04620110, the solubility of PF-04620110 in water, the solubility of PF-04620110 in DMSO, the solubility of PF-04620110 in PBS buffer, the animal experiment (test) of PF-04620110, the cell expriment (test) of PF-04620110, the in vivo, in vitro and clinical trial test of PF-04620110, the EC50, IC50,and Affinity of PF-04620110, Please contact DC Chemicals. |